Johnson & Johnson (JNJ)

142.85
NYSE : Health Technology
Prev Close 142.98
Day Low/High 141.23 / 143.97
52 Wk Low/High 109.16 / 157.00
Avg Volume 8.25M
Exchange NYSE
Shares Outstanding 2.63B
Market Cap 376.69B
EPS 5.70
P/E Ratio 22.31
Div & Yield 4.04 (2.74%)
Jim Cramer on Who's in Play Now That Allergan and Pfizer Won't Merge

Jim Cramer on Who's in Play Now That Allergan and Pfizer Won't Merge

TheStreet's Jim Cramer says some biotech companies could be in play after the end of the deal between Pfizer and Allergan.

Potential Johnson & Johnson Correction Could Equal Buying Opportunity

Potential Johnson & Johnson Correction Could Equal Buying Opportunity

Shares of the pharmaceutical company are headed in the right direction, but the pace of the rally is slowing. 

Pfizer Tops Interbrand's List of Best Biopharmaceutical Brands

Pfizer Tops Interbrand's List of Best Biopharmaceutical Brands

Pfizer scored the top spot in Interbrand Health's inaugural ranking of the top ten biopharmaceutical brands.

Jim Cramer Says J&J, IBM, Alphabet Look Cheaper With Weaker Dollar

Jim Cramer Says J&J, IBM, Alphabet Look Cheaper With Weaker Dollar

Heading into the second quarter, TheStreet's Jim Cramer believes stocks might be a little bit cheaper than investors realize, including Johnson & Johnson (JNJ), IBM (IBM) and Alphabet (GOOG).

Medivation Surges on Takeover Chatter; Wall Street Scouts for Big Pharma M&A

Medivation Surges on Takeover Chatter; Wall Street Scouts for Big Pharma M&A

Medivation is surging as Wall Street scouts the Big Pharma front for discounted M&A opportunities.

Cramer Says Stryker an Attractive Target for Johnson & Johnson

Cramer Says Stryker an Attractive Target for Johnson & Johnson

As Johnson & Johnson surveys the M&A scene, investors would be wise to keep Stryker on their radars, Real Money's Jim Cramer says.

Here's Why I Think Amgen Is the Best Company in the S&P 500

Here's Why I Think Amgen Is the Best Company in the S&P 500

What's the best company in the S&P 500?

Jim Cramer: Valeant Needs a Government Monitor

Jim Cramer: Valeant Needs a Government Monitor

TheStreet's Jim Cramer said Valeant Pharmaceuticals' (VRX) move to appoint billionaire investor Bill Ackman to the board of directors isn't enough and a government monitor is needed.

Jim Cramer Likes Johnson & Johnson Over Eli Lilly in Pharma Sector

Jim Cramer Likes Johnson & Johnson Over Eli Lilly in Pharma Sector

TheStreet's Jim Cramer says Gilead (GILD) needs to make an acquisition to jump start its business.

Cramer: No Sweat, the Fed's Got This

Cramer: No Sweat, the Fed's Got This

And we can stop calling the dollar 'super-freaking strong.'

Johnson & Johnson upgraded at Goldman

A Double Cup of Johnson & Johnson

A Double Cup of Johnson & Johnson

The stock is a good risk/reward candidate at its current level.

Jim Cramer Says Avoid Airlines on Capacity Woes, Buy Eli Lilly

Jim Cramer Says Avoid Airlines on Capacity Woes, Buy Eli Lilly

TheStreet’s Jim Cramer commented on United Airlines and JetBlue on Tuesday from the floor of the New York Stock Exchange.

CLOSED: Intermediate Trade: Johnson & Johnson

CLOSED: Intermediate Trade: Johnson & Johnson

I'm closing this trade as the gain/profit target has been met.

Four Blue Chip Stocks to Weather a Market Storm

Four Blue Chip Stocks to Weather a Market Storm

Microsoft’s stock eclipsed the $50 barrier last fall for the first time since March 2000.

Cramer: Clearer Presidential Race Helps Stocks Pick Up Pace

It seems to be coming down to Hillary Clinton and Donald Trump, and both would be positive for business.

Jim Cramer Says Consumer Stocks Like Clorox 'Have it All' Right Now

Jim Cramer Says Consumer Stocks Like Clorox 'Have it All' Right Now

Jim Cramer says consumer products companies like Clorox, PepsiCo, and Procter & Gamble have the best stock charts right now.

Cramer: 17 Stocks Blessed by Charts and Fundamentals

Cramer: 17 Stocks Blessed by Charts and Fundamentals

Which stocks seem to have it all right now?

Cramer: Hail to Those Who Choose Wisely

Cramer: Hail to Those Who Choose Wisely

Finding stocks that are caught in the market vortex but shouldn't be going down is the key to coming out a winner.

Trending Tickers: DIS, BAC, JNJ, PFE

Trending Tickers: DIS, BAC, JNJ, PFE

Janet Yellen's Congressional hearing and volatile oil prices are not enough to hurt the stock market. 

U.S. Futures Tick Higher as Janet Yellen Worries Over Economy

U.S. futures look to build off of Tuesday's afternoon rally.

Companies Come Under More Pressure to Cut Costs and Boost Share Buybacks

Companies Come Under More Pressure to Cut Costs and Boost Share Buybacks

As we're talking ourselves into a recession, pressures on executives increase.

Cramer: It's the Attack of the Killer Quarters!

Cramer: It's the Attack of the Killer Quarters!

These major names still have higher to climb.

Cramer: The Fed Interest Rate Hike Hurts the American Worker

Cramer: The Fed Interest Rate Hike Hurts the American Worker

Janet Yellen and her colleagues should listen to companies' conference calls.

Calm Down, It's Just an Oversold Bounce

Calm Down, It's Just an Oversold Bounce

But this was a good day to be a contrarian.

U.S. Stocks Recover Tuesday on Upbeat Earnings and Uptick in Oil Prices

U.S. Stocks Recover Tuesday on Upbeat Earnings and Uptick in Oil Prices

Wall Street roared back Tuesday as crude oil prices bounced higher and several companies reported strong earnings.

Base Metals Surprise With Price Rise

Base Metals Surprise With Price Rise

Despite another drop in Chinese equities, copper and zinc have rallied more than 2%.

Cramer: A Solid Day That Defied Its Start

Cramer: A Solid Day That Defied Its Start

Along came quality earnings from a few solid companies and the narrative changed.

Cramer: Terrible Trio May Have Met Their Match

Cramer: Terrible Trio May Have Met Their Match

Oil, Fed and China taken down a peg -- for now.

Stodgy Industrials Are Driving the Bounce

But it takes time for good charts to develop, and we are still struggling to establish a solid low.